| Dr David Ferrell Butler, MD | |
|
232 S Woods Mill Rd, Suite 110 East, Chesterfield, MO 63017-3417 | |
| (314) 542-4998 | |
| (314) 542-4739 |
| Full Name | Dr David Ferrell Butler |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 35 Years |
| Location | 232 S Woods Mill Rd, Chesterfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598789489 | NPI | - | NPPES |
| 206930208 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 105395 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital - St Louis | Richmond heights, MO | Hospital |
| Osf Saint Anthony's Health Center | Alton, IL | Hospital |
| St Louis University Hospital | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Health Care Group | 0143608372 | 678 |
| Ssm Medical Group Inc | 6608776299 | 491 |
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Volcano Corporation today announced the pricing of its offering of $100 million aggregate principal amount of 2.875 percent convertible senior notes due September 1, 2015 registered under the Securities Act of 1933, as amended. Prior to June 1, 2015, the notes will be convertible only upon certain circumstances.
Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.
Processed and fast foods enriched with phosphorus additives may play a role in health disparities in chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Block Imaging International, Inc., the premier global provider of Pre-owned and Refurbished Medical Imaging Systems, Parts, and Services, announced today its acquisition of Benchmark Radiology LLC., headquartered near Ft. Wayne, IN.
› Verified 9 days ago
| Entity Name | Ssm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700966207 PECOS PAC ID: 6608776299 Enrollment ID: O20040729001034 |
News Archive
Volcano Corporation today announced the pricing of its offering of $100 million aggregate principal amount of 2.875 percent convertible senior notes due September 1, 2015 registered under the Securities Act of 1933, as amended. Prior to June 1, 2015, the notes will be convertible only upon certain circumstances.
Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.
Processed and fast foods enriched with phosphorus additives may play a role in health disparities in chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Block Imaging International, Inc., the premier global provider of Pre-owned and Refurbished Medical Imaging Systems, Parts, and Services, announced today its acquisition of Benchmark Radiology LLC., headquartered near Ft. Wayne, IN.
› Verified 9 days ago
| Entity Name | Physician Specialists Of St Lukes Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235168410 PECOS PAC ID: 1557366960 Enrollment ID: O20060918000462 |
News Archive
Volcano Corporation today announced the pricing of its offering of $100 million aggregate principal amount of 2.875 percent convertible senior notes due September 1, 2015 registered under the Securities Act of 1933, as amended. Prior to June 1, 2015, the notes will be convertible only upon certain circumstances.
Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.
Processed and fast foods enriched with phosphorus additives may play a role in health disparities in chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Block Imaging International, Inc., the premier global provider of Pre-owned and Refurbished Medical Imaging Systems, Parts, and Services, announced today its acquisition of Benchmark Radiology LLC., headquartered near Ft. Wayne, IN.
› Verified 9 days ago
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
Volcano Corporation today announced the pricing of its offering of $100 million aggregate principal amount of 2.875 percent convertible senior notes due September 1, 2015 registered under the Securities Act of 1933, as amended. Prior to June 1, 2015, the notes will be convertible only upon certain circumstances.
Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.
Processed and fast foods enriched with phosphorus additives may play a role in health disparities in chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Block Imaging International, Inc., the premier global provider of Pre-owned and Refurbished Medical Imaging Systems, Parts, and Services, announced today its acquisition of Benchmark Radiology LLC., headquartered near Ft. Wayne, IN.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Ferrell Butler, MD 232 S Woods Mill Rd, Suite 110 East, Chesterfield, MO 63017-3417 Ph: (314) 542-4998 | Dr David Ferrell Butler, MD 232 S Woods Mill Rd, Suite 110 East, Chesterfield, MO 63017-3417 Ph: (314) 542-4998 |
News Archive
Volcano Corporation today announced the pricing of its offering of $100 million aggregate principal amount of 2.875 percent convertible senior notes due September 1, 2015 registered under the Securities Act of 1933, as amended. Prior to June 1, 2015, the notes will be convertible only upon certain circumstances.
Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.
Processed and fast foods enriched with phosphorus additives may play a role in health disparities in chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.
Block Imaging International, Inc., the premier global provider of Pre-owned and Refurbished Medical Imaging Systems, Parts, and Services, announced today its acquisition of Benchmark Radiology LLC., headquartered near Ft. Wayne, IN.
› Verified 9 days ago
Dr. James Z. Chen, MD Radiology Medicare: Medicare Enrolled Practice Location: 14014 Camberra Ct, Chen's Radiation, Chesterfield, MO 63017 Phone: 314-469-6893 | |
Peter Holtz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6100 Fax: 314-878-5437 | |
Dr. Charles Garvin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6100 Fax: 314-878-5437 | |
Dr. Jennifer Lee Demertzis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-434-1500 Fax: 314-548-4748 | |
Dr. Robert Kanterman, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6100 Fax: 314-878-5437 | |
Dr. Naris Rujanavech, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6100 Fax: 314-878-5437 | |
Michael J Stadnyk, M. D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 36 Chesterfield Lake Road, Chesterfield, MO 63005 Phone: 573-334-6071 Fax: 573-334-4739 |